"10.1371_journal.pone.0029798","plos one","2012-01-11T00:00:00Z","Ronald K Blackman; Kahlin Cheung-Ong; Marinella Gebbia; David A Proia; Suqin He; Jane Kepros; Aurelie Jonneaux; Philippe Marchetti; Jerome Kluza; Patricia E Rao; Yumiko Wada; Guri Giaever; Corey Nislow","Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America; Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Toronto, Ontario, Canada; UMR 837 – INSERM, Université de Lille II & CHRU LILLE, Lille, France","Conceived and designed the experiments: CN RKB DAP PM J. Kluza. Performed the experiments: CN MG KC-O RKB DAP SH J. Kepros AJ. Analyzed the data: RKB CN GG DAP PM J. Kluza PER YW. Wrote the paper: RKB CN.","RKB, DAP, SH, J. Kepros, PER and YW are or were employees of Synta Pharmaceuticals, Corp. Elesclomol is a Synta product. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no other competing interests to declare.","2012","01","Ronald K Blackman","RKB",13,TRUE,5,7,6,2,TRUE,TRUE,TRUE,2,"10;11",TRUE
